Historical Stock Price
CERU historical stock prices picture
CERU (CERU) has the following price history information. Looking back at CERU historical stock prices for the last five trading days, on July 14, 2017, CERU opened at $0.70, traded as high as $0.74 and as low as $0.68, and closed at $0.70. Trading volume was a total of 739.70K shares. On July 17, 2017, CERU opened at $0.70, traded as high as $0.70 and as low as $0.62, and closed at $0.65. Trading volume was a total of 951.30K shares. On July 18, 2017, CERU opened at $0.67, traded as high as $0.70 and as low as $0.60, and closed at $0.63. Trading volume was a total of 734.00K shares. On July 19, 2017, CERU opened at $0.68, traded as high as $0.88 and as low as $0.63, and closed at $0.66. Trading volume was a total of 6.24M shares. On July 20, 2017, CERU opened at $6.56, traded as high as $6.56 and as low as $6.56, and closed at $6.56. Trading volume was a total of 0 shares.

CERU Historical Stock Prices By Date:

CERU historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CERU shares, starting with a $10,000 purchase of CERU, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/11/2014
End date: 07/20/2017
Start price/share: $68.50
End price/share: $6.56
Dividends collected/share: $0.00
Total return: -90.42%
Average Annual Total Return: -51.13%
Starting investment: $10,000.00
Ending investment: $957.37
Years: 3.28
Date Open High Low Close Volume
07/14/2017 $0.70 $0.74 $0.68 $0.70 739.70K
07/17/2017 $0.70 $0.70 $0.62 $0.65 951.30K
07/18/2017 $0.67 $0.70 $0.60 $0.63 734.00K
07/19/2017 $0.68 $0.88 $0.63 $0.66 6.24M
07/20/2017 $6.56 $6.56 $6.56 $6.56 0
Cerulean Pharma is a clinical-stage, oncology-focused company applying its proprietary Dynamic Tumor Targeting™ Platform to develop various therapies. Co.'s platform is designed to create nanoparticle-drug conjugates, which consist of anti-cancer therapeutics, or payloads, covalently linked to a proprietary polymer. Co.'s principal clinical candidate, CRLX101, is in Phase 2 clinical development in patients with renal cell carcinoma and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer in combination with Avastin® (bevacizumab) and paclitaxel, respectively. Co.'s second clinical candidate, CRLX301, is in Phase 1/2a clinical development.
Date Close
07/14/2017$0.70
07/17/2017$0.65
07/18/2017$0.63
07/19/2017$0.66
07/20/2017$6.56
CERU is categorized under the Healthcare sector; below are some other companies in the same sector:

CFMS Historical Stock Prices
CFN Historical Stock Prices
CFRX Historical Stock Prices
CFRXU Historical Stock Prices
CFRXW Historical Stock Prices
CFRXZ Historical Stock Prices
CGEN Historical Stock Prices
CGIX Historical Stock Prices
CGNT Historical Stock Prices
CHDX Historical Stock Prices

Email EnvelopeFree CERU Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CERU Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.